Cells undergo reversible adaptations (hypertrophy, hyperplasia, atrophy, metaplasia) when stressed, but exceed their capacity for compensation, leading to irreversible injury through necrosis or apoptosis. The morphologic and functional changes characterize the transition from health to disease.
Map specific cellular adaptations to organ systems: cardiac hypertrophy in hypertension, gastric metaplasia in chronic reflux, atrophy in denervated muscle.
Adaptation and injury are not sharply divided—cells exist on a continuum of stress response. Morphologic change does not always indicate functional loss.
Cells are not passive victims of their environment—they actively respond to stress in ways designed to preserve function. When a cardiomyocyte faces chronically elevated blood pressure, it grows larger (hypertrophy) to generate more contractile force. When the stomach lining is repeatedly injured by acid, it may replace its columnar cells with tougher squamous epithelium (metaplasia). When demand on a tissue drops—say, a muscle loses its nerve supply—cells shrink (atrophy). These adaptations represent the cell's attempt to reach a new equilibrium; they are not injury, though they indicate that normal conditions have been disturbed.
The critical question in pathophysiology is: when does adaptation become injury? The answer lies on a continuum rather than at a sharp threshold, but the key variable is the cell's energy state. Nearly every homeostatic mechanism—pumping ions across membranes, synthesizing repair proteins, extruding calcium—requires ATP. When injury depletes ATP (as in ischemia) or directly damages mitochondria (as in certain toxins), the cell's ability to maintain these mechanisms degrades in a cascade. Early on, changes like cellular swelling and fatty accumulation are fully reversible if the stress is relieved. The cell is sick but not dying.
Irreversibility is crossed when two events occur: the plasma membrane ruptures, and the cell's nuclei begin to degrade. Membrane rupture means the cell can no longer contain itself or exclude the outside world; nuclear changes (pyknosis → karyorrhexis → karyolysis) confirm that DNA is being destroyed. These are the morphologic hallmarks of necrosis—an uncontrolled, inflammatory cell death. Apoptosis, by contrast, is a programmed, energy-requiring process that dismantles the cell neatly without triggering inflammation. Both are forms of irreversible injury, but they differ fundamentally in mechanism and consequence for surrounding tissue.
Mitochondria sit at the center of this story because they are simultaneously the cell's power plant and a key regulator of apoptosis. Sustained ATP depletion is lethal; but mitochondria also release cytochrome c when damaged, which triggers the apoptotic cascade. This means a cell under moderate stress may be guided toward a clean apoptotic death rather than a messy necrotic one—a distinction that matters greatly to whether nearby tissue becomes inflamed. Understanding which pathway is activated (and why) is foundational to understanding virtually every disease process that follows, from acute inflammation to cancer.